THYROCARE TECHNOLOGIES
|
THYROCARE TECHNOLOGIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.12 | 13.42 | 12.47 | 33.28 | 21.14 |
| CEPS(Rs) | 27.55 | 22.00 | 19.47 | 39.70 | 27.13 |
| DPS(Rs) | 21.00 | 18.00 | - | 15.00 | 25.00 |
| Book NAV/Share(Rs) | 102.36 | 98.67 | 100.09 | 98.89 | 80.26 |
| Tax Rate(%) | 37.60 | 27.60 | 27.35 | 22.65 | 25.79 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.80 | 24.26 | 23.27 | 40.03 | 34.62 |
| EBIT Margin(%) | 21.71 | 17.75 | 17.74 | 39.22 | 31.00 |
| Pre Tax Margin(%) | 21.16 | 16.78 | 16.82 | 38.67 | 30.83 |
| PAT Margin (%) | 13.20 | 12.15 | 12.22 | 29.91 | 22.88 |
| Cash Profit Margin (%) | 21.24 | 20.37 | 19.57 | 35.66 | 29.00 |
| Performance Ratios | |||||
| ROA(%) | 13.82 | 10.00 | 8.00 | 25.38 | 22.43 |
| ROE(%) | 17.04 | 13.21 | 12.23 | 37.18 | 28.75 |
| ROCE(%) | 27.25 | 18.75 | 17.61 | 48.42 | 38.51 |
| Asset Turnover(x) | 1.05 | 0.82 | 0.65 | 0.85 | 0.98 |
| Sales/Fixed Asset(x) | 1.32 | 1.19 | 1.19 | 1.49 | 1.36 |
| Working Capital/Sales(x) | 3.18 | 3.04 | 2.69 | 2.87 | 4.71 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.76 | 0.84 | 0.84 | 0.67 | 0.73 |
| Receivable days | 30.92 | 41.03 | 61.79 | 42.73 | 22.50 |
| Inventory Days | 24.97 | 23.99 | 18.09 | 14.84 | 16.23 |
| Payable days | 111.10 | 70.18 | 45.30 | 44.68 | 52.19 |
| Valuation Parameters | |||||
| PER(x) | 39.72 | 44.13 | 34.45 | 23.25 | 42.72 |
| PCE(x) | 24.69 | 26.92 | 22.07 | 19.49 | 33.28 |
| Price/Book(x) | 6.64 | 6.00 | 4.29 | 7.82 | 11.25 |
| Yield(%) | 3.09 | 3.04 | - | 1.94 | 2.77 |
| EV/Net Sales(x) | 5.16 | 5.45 | 4.26 | 6.93 | 9.62 |
| EV/Core EBITDA(x) | 17.24 | 21.05 | 17.15 | 15.39 | 25.90 |
| EV/EBIT(x) | 23.79 | 30.71 | 24.04 | 17.66 | 31.03 |
| EV/CE(x) | 6.49 | 5.68 | 4.20 | 4.81 | 8.81 |
| M Cap / Sales | 5.24 | 5.48 | 4.32 | 6.95 | 9.65 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 20.19 | 8.58 | -10.56 | 19.05 | 13.90 |
| Core EBITDA Growth(%) | 39.00 | 13.12 | -50.58 | 44.25 | 1.91 |
| EBIT Growth(%) | 46.98 | 8.66 | -59.55 | 50.60 | 7.79 |
| PAT Growth(%) | 30.59 | 7.97 | -63.46 | 55.67 | 28.00 |
| EPS Growth(%) | 27.62 | 7.58 | -62.52 | 57.45 | 26.18 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.04 | - | - | - |
| Current Ratio(x) | 2.77 | 3.08 | 3.54 | 1.95 | 2.10 |
| Quick Ratio(x) | 2.39 | 2.55 | 3.18 | 1.84 | 1.86 |
| Interest Cover(x) | 39.68 | 18.36 | 19.34 | 71.94 | 176.25 |
| Total Debt/Mcap(x) | - | 0.01 | - | - | - |
Compare Financial Ratios of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹7,208.9 Cr | -1.8% | 10.3% | 44% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹108,308.0 Cr | -3.7% | -1.7% | 9.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹106,781.0 Cr | -4.2% | -4% | 9.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹74,899.4 Cr | -3.7% | -6% | 60.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,038.4 Cr | 1.5% | 1.9% | 49.5% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,767.0 Cr | -7.4% | -14.7% | 16.9% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -1.8% |
10.3% |
44% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses
